AstraZeneca - AZN Share Forecast, Price & News

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last twelve months. There are currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" AZN shares.
View AZN analyst ratings or view top-rated stocks.

8 Wall Street research analysts have issued twelve-month target prices for AstraZeneca's stock. Their AZN share price forecasts range from GBX 6,950 to £135. On average, they predict the company's share price to reach £118.72 in the next twelve months. This suggests a possible upside of 6.6% from the stock's current price.
View analysts price targets for AZN or view top-rated stocks among Wall Street analysts.

AstraZeneca's stock was trading at £112.18 at the beginning of the year. Since then, AZN stock has decreased by 0.7% and is now trading at £111.34.
View the best growth stocks for 2023 here.

AstraZeneca declared a dividend on Thursday, February 9th. Shareholders of record on Thursday, February 23rd will be given a dividend of GBX 162.80 per share on Monday, March 27th. This represents a yield of 1.51%. The ex-dividend date is Thursday, February 23rd. This is a boost from the stock's previous dividend of GBX 76.40. The official announcement can be viewed at this link.
Read our dividend analysis for AZN.

AstraZeneca (LON:AZN) pays an annual dividend of GBX 239 per share and currently has a dividend yield of 2.22%. The dividend payout ratio is 13,735.63%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for AZN.

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GSK (GSK), NVIDIA (NVDA), Gilead Sciences (GILD), Intel (INTC), Vodafone Group Public (VOD), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE), QUALCOMM (QCOM) and The Hain Celestial Group (HAIN).

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

Shares of AZN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of AZN stock can currently be purchased for approximately £111.34.

AstraZeneca (LON:AZN) has a market capitalization of £172.58 billion and generates £44.35 billion in revenue each year. The biopharmaceutical company earns £3.29 billion in net income (profit) each year or GBX 1.74 on an earnings per share basis.

The company employs 83,100 workers across the globe.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The official website for the company is www.astrazeneca.com. The biopharmaceutical company can be reached via phone at +44-20-73045000.